Title of Medical Course (CME Video Course):
Harvard Medical School Pulmonary and Critical Care Medicine 2023
Harvard Pulmonary and Critical Care Medicine 2023
Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures and Challenging Cases
Pulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. The 2023 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.
OVERVIEW
This comprehensive course provides education and updates to optimize your care of patients with:
- Post-acute sequelae of COVID-19
- Chronic cough
- COPD
- Asthma
- Lung nodules
- Lung cancer
- Sleep-disordered breathing
- GERD
- Sepsis
- ARDS
- Sarcoidosis
- IPF
- Pleural disease
- Pneumonia
- Tuberculosis
- Surgical emergencies
- Thromboembolism
- Lung transplantation
- Neurologic issues in the ICU
- Septic shock
- Interstitial lung disease
- Bronchiectasis
- Cystic fibrosis
- Atypical mycobacterial disease
- Pulmonary hypertension
- Cardiopulmonary disorders
- Complications from cardiac arrest
- Hypersensitivity pneumonitis
- Occupational and environmental lung disease
- Acute respiratory failure
- Vaping-related lung disease
- Hemorrhage and ANCA-associated disease
REASONS TO ATTEND IN 2023
All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:
- COVID-19, PASC, and emerging diseases
- Advanced techniques in interventional pulmonology
- High-flow oxygen therapy for respiratory failure
- New biologics for asthma
- Lung microbiome: emerging implications for lung health
- Emerging evidence for targeted temperature management
- Evaluating occupational and environmental lung disease
- Prescribing medications for interstitial lung disease
- Pulmonary embolus: the latest treatment strategies
- State-of-the-art management of the critically ill patient
- Guidance to conduct end-of-life discussions
- Updates in pulmonary pathology
- New treatment options in cystic fibrosis
- Handling neurologic and surgical emergencies in the medical ICU
- The state of the art in interventional bronchoscopy
- The most current guidelines for treating sepsis
- Evidence-based treatment of ARDS
- Updates on vaping-related lung disease
- New therapeutics in the age of immunology
- Guidance to navigate controversies surrounding therapeutic hypothermia and post-cardiac arrest prognosis
- New approaches that improve outcomes for patients with unexplained chronic cough
- Current guidelines for management of pulmonary nodules
- Targeted therapies and immunotherapies for lung cancer
- When to consider lung transplantation and eligibility
- When and how to use the newest drugs in IPF
- Expert advice on atypical mycobacterial diagnostics and therapy
- New concepts in the use of vasopressors in septic shock
- New drugs and combinations in pulmonary hypertension
- New evidence on sedation, analgesia, and early mobility
- Point-of-care pulmonary ultrasound in the intensive care unit
Schedule
Sunday, April 23
Welcome – David J. Kanarek, MD
GERD in Pulmonology – David J. Kanarek, MD
Lung Transplantation: Referral, Patient Selection, Lung Allocation and COVID – Brian Keller, MD
New Approaches to the Unexplained Chronic Cough – Kai Saukkonen, MD
Occupational and Environmental Lung Disease – L. Christine Oliver, MD
Cystic Fibrosis and Bronchiectasis: Understanding CFTR and New Treatment – Isabel Neuringer, MD
The Microbiome and Lung Disease – Peggy Lai, MD
Q & A Session with Speakers – Drs. Kanarek, Keller, Lai, Neuringer, Oliver, Saukkonen, and Angela Frank, MD, MPH
Pulmonary Pathology: Interstitial Lung Disease – Lida Hariri, MD, PhD
Diagnosis and Management of IPF: When, Why, and How to Use the Newest Drugs – Sydney Montesi, MD
Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD – Barry Shea, MD
Hypersensitivity Pneumonitis: Pigeons, Farmers, and Hot Tubs, Oh My! – Rachel Knipe, MD
Treatment Challenges of Pulmonary Sarcoidosis – Robert Hallowell, MD
Palliative Care in Advanced Lung Disease – Bethany-Rose Daubman, MD
Q & A Session with Speakers – Drs. Daubman, Hallowell, Hariri, Knipe, Shea, and Kathryn Hibbert, MD
Monday, April 24
ARDS: State-of-the-Art Strategies to Protect the Lung Kathryn Hibbert, MD
Noninvasive Respiratory Support for Acute Respiratory Failure: Less May Not Be Best Carolyn La Vita, MHA, RRT
Fluid Responsiveness Alexandra Wong, MD
Break Novel Ventilator Modes: The Hype and Reality Carolyn La Vita, MHA, RRT
Vasopressors in Septic Shock: Old Friends and New Jason Griffith, MD, PhD
Critical Care Echo 2.0: The Whys and Hows of Assessing Cardiac Output Jonah Rubin, MD
Q & A with Speakers Drs. Kanarek, North, Rubin, and Wong, and Carolyn La Vita, MHA, RRT
Emerging Infectious Diseases – Paul Biddinger, MD
The Legacy of COVID: A Clinical Approach to Post-Acute Sequelae of COVID – Leo Ginns, MD
Looking Ahead: New Discoveries and Ongoing Investigation into PASC – George Alba, MD
Approach to the Immunocompromised Critically Ill Patient – Lisa Bebell, MD
Vaping-Associated Acute Lung Injury – David Christiani, MD, MPH, MS
COVID-19: Novel Therapeutics and New Developments – Alyssa Letourneau, MD
Expanded Q & A Session – Drs. Alba, Bebell, Biddinger, Christiani, Ginns, Hibbert, and Letourneau
Tuesday, April 25
Common Neurologic Issues in the ICU – Sahar Zafar, MD
From Ancient Egypt to Balanced Crystalloids: Medicine’s Attempts to Manage Sepsis – Eric Schmidt, MD
Sedation, Analgesia and Early Mobility: The State of the Art in 2023 – Crystal North, MD, MPH
TTM and Neuroprognostication after Cardiac Arrest – David Greer, MD
Prognosis and Uncertainty in the ICU – Emily Rubin, MD
Surgical Emergencies in the Medical ICU – Noelle Saillant, MD
Q & A with Speakers – Drs. Frank, Greer, Griffith, Rubin, Saillant, Schmidt, and Zafar
Thrombotic Mechanisms and Antithrombotic Agents: How Do the New Oral Agents Fit in 2023? – Rachel Rosovsky, MD, MPH
Pulmonary Embolism: An Update – Alison Witkin, MD
Pulmonary Hypertension: Evaluation and Management – Josanna Rodriguez-Lopez, MD
Vasculitis and ANCA – John Niles, MD
Exercise and Cardiopulmonary Disorders: Indications and Interpretation – C. Corey Hardin, MD, PhD
Q & A with Speakers – Drs. Hardin, Hibbert, Niles, Rodriguez-Lopez, Rosovsky, and Witkin
Wednesday, April 26
Pleural Disease: 2023 Updates – Fayez Kheir, MD, MSc
Interventional Pulmonology in 2023 – Erik Folch, MD
Interventional Bronchoscopy in COPD: Valves, Coils, and Beyond – Colleen Keyes, MD, MPH
Extended Q & A with Interventional Pulmonary Faculty – Drs. Folch, Frank, Keyes, and Kheir
Looking Deeper: Patterns and Insights from Chest Radiology – Amita Sharma, MBBS
A Strategic Approach to the Management of Pulmonary Nodules – Angela Frank, MD, MPH
Treatment of Non-Small Cell Lung Cancer: Traditional Chemotherapy, Targeted Therapy, and Immunotherapies – Jaime Schneider, MD, PhD
COPD 2023 – Walter O’Donnell, MD
Asthma: Ensuring Your Treatment Approaches Are Current with the State of the Art – Jehan Alladina, MD
New Therapeutics in Lung Disease: The Age of Immunotherapy – Benjamin Medoff, MD
Community Acquired Pneumonia: The Newest Guidelines and State-of-the-Art Treatment Strategies – Joshua Metlay, MD, PhD
Tuberculosis in 2023 – Maha Farhat, MD, MSc
Non-Tuberculous Mycobacterial Disease: Navigating the Labyrinth – Rocío Hurtado, MD, DTM&H
Q & A with Speakers – Drs. Alladina, Farhat, Frank, Hibbert, Hurtado, Medoff, Metlay, Montesi, O’Donnell, Schneider, and Sharma
Thursday, April 27
Obstructive Sleep Apnea James Mojica, MD, FAASM
Central Sleep Apnea 2023 James Mojica, MD, FAASM
Break Sleep Diagnostics Katherine Dudley, MD
Noninvasive Ventilation for Neuromuscular Disorders and Alveolar Hypoventilation Syndromes Katherine Dudley, MD
Q & A Session Drs. Dudley, Kanarek, and Mojica
Reviews
There are no reviews yet.